DNA hypermethylation on multiple CpG islands associated with increased DNA methyltransferase DNMT1 protein expression during multistage urothelial carcinogenesis

Journal of Urology

Volumn 173, Issue 5, 2005, Pages 1767-1771

  Nakagawa, Tohru ^a,b   Kanai, Yae ^a   Ushijima, Saori ^a   Kitamura, Tadaichi ^b   Kakizoe, Tadao ^c   Hirohashi, Setsuo ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c NATIONAL CANCER CENTER   (Japan)

Author keywords

Bladder; Carcinoma, transitional cell; CpG islands; DNA; Phenotype

Indexed keywords

BISULFITE; DEATH ASSOCIATED PROTEIN KINASE; DNA METHYLTRANSFERASE 1; PROTEIN P16;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER INVASION; CARCINOGENESIS; CARCINOMA IN SITU; CONTROLLED STUDY; CORRELATION ANALYSIS; CPG ISLAND; DNA METHYLATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR CLONING; PAPILLARY CARCINOMA; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESTRICTION MAPPING; TRANSITIONAL CELL CARCINOMA; UROGENITAL TRACT TUMOR; UROTHELIUM;

EID: 17144413410     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000154632.11824.4d     Document Type: Article

References (20)

1. Jones, P. A. and Baylin, S. B.: The fundamental role of epigenetic events in cancer. Nat Rev Genet, 8: 415, 2002
2. Maruyama, R., Toyooka, S., Toyooka, K. O., Harada, K., Virmani, A. K., Zochbauer-Muller, S. et al: Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features. Cancer Res, 61: 8659, 2001
3. Horikawa, Y., Sugano, K., Shigyo, M., Yamamoto, H., Nakazono, M., Fujimoto, H. et al: Hypermethylation of an E-cadherin (CDH1) promoter region in high grade transitional cell carcinoma of the bladder comprising caicinoma in situ. J Urol, 169: 1541, 2003
4. Toyota, M., Ahuja, N., Ohe-Toyota, M., Herman, J. G., Baylin, S. B. and Issa, J. P.: CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA, 98: 8681, 1999
5. Kanal, Y., Ushijima, S., Kondo, Y., Nakanishi, Y. and Hirohashi, S.: DNA methyltransferase expression and DNA methylation of CpG islands and peri-centromeric satellite regions in human colorectal and stomach cancers. Int J Cancer, 91: 205, 2001
6. Etoh, T., Kanai, Y., Ushijima, S., Nakagawa, T., Nakanishi, Y., Sasako, M. et al: Increased DNA methyltransferase 1 (DNMT1) protein expression correlates significantly with poorer tumor differentiation and frequent DNA hypermethylation of multiple CpG islands in gastric cancers. Am J Pathol, 164: 689, 2004
7. Nakagawa, T., Kanai, Y., Saito, Y., Kitamura, T., Kakizoe, T. and Hirohashi, S.: Increased DNA methyltransferase 1 protein expression in human transitional cell carcinoma of the bladder. J Urol, 170: 2463, 2003
8. Sobin, L. H. and Wittekind, C. H.: TNM Classification of Malignant Tumors, 5th ed. New York: Wiley-Liss, Inc., 1997
9. Herman, J. G., Graff, J. R., Myohanen, S., Nelkin, B. D. and Baylin, S. B.: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA, 93: 9821, 1996
10. Xiong, Z. and Laird, P. W.: COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res, 25: 2532, 1997
11. Satoh, A., Toyota, M., Itoh, F., Kikuchi, T., Obata, T., Sasaki, Y. et al: DNA methylation and histone deacetylation associated with silencing DAP kinase gene expression in colorectal and gastric cancers. Br J Cancer, 86: 1817, 2002
12. Harris, A. L. and Neal, D. E.: Bladder cancer - field versus clonal origin. N Engl J Med, 326: 759, 1992
13. Friedell, G. H., Parija, G. C., Nagy, G. K. and Soto, E. A.: The pathology of human bladder cancer. Cancer, 45: 1823, 1980
14. Spruck, C. H., 3rd, Ohneseit, P. F., Gonzalez-Zulueta, M., Esrig, D., Miyao, N., Tsai, Y. C. et al: Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res, 54: 784, 1994
15. Chang, W. Y., Cairns, P., Schoenberg, M. P., Polascik, T. J. and Sidransky, D.: Novel suppressor loci on chromosome 14q in primary bladder cancer. Cancer Res, 55: 3246, 1995
16. Chuang, L. S., Ian, H. I., Koh, T. W., Ng, H. H., Xu, G. and Li, B. F.: Human DNA-(cytosine-5) methyltransferase-PCNA complex as a target for p21WAF1. Science, 277: 1996, 1997
17. Baylin, S. B.: Tying it all together: epigenetics, genetics, cell cycle and cancer. Science, 277: 1948, 1997
18. Vertino, P. M., Yen, R. W., Gao, J. and Baylin, S. B.: De novo methylation of CpG island sequences in human fibroblasts overexpressing DNA (cytosine-5-)-methyltransferase. Mol Cell Biol, 16: 4555, 1996
19. Rhee, I., Bachman, K. E., Park, B. H., Jair, K. W., Yen, R. W., Schuebel, K. E. et al: DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature, 416: 552, 2002
20. Lee, P. J., Washer, L. L., Law, D. J., Boland, C. R., Horon, I. L. and Feinberg, A. P.: Limited up-regulation of DNA methyltransferase in human colon cancer reflecting increased cell proliferation. Proc Natl Acad Sci USA, 93: 10366, 1996